[
  {
    "ts": null,
    "headline": "Mettler-Toledo International Inc. (MTD) Navigating Through Uncertain Macro Backdrop",
    "summary": "Mettler-Toledo International Inc. (NYSE:MTD) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 9, Catherine Schulte from Baird reiterated her Neutral rating on Mettler-Toledo International Inc. (NYSE:MTD). In the process, she also raised the price target on the stock slightly from $1,444 to $1,445. Schulte shared an […]",
    "url": "https://finnhub.io/api/news?id=c44c5b9f0cf76d9b8a85150ea8023cd401d6352d7cc12fe722f069d4324f7380",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771962200,
      "headline": "Mettler-Toledo International Inc. (MTD) Navigating Through Uncertain Macro Backdrop",
      "id": 139201055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MTD",
      "source": "Yahoo",
      "summary": "Mettler-Toledo International Inc. (NYSE:MTD) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 9, Catherine Schulte from Baird reiterated her Neutral rating on Mettler-Toledo International Inc. (NYSE:MTD). In the process, she also raised the price target on the stock slightly from $1,444 to $1,445. Schulte shared an […]",
      "url": "https://finnhub.io/api/news?id=c44c5b9f0cf76d9b8a85150ea8023cd401d6352d7cc12fe722f069d4324f7380"
    }
  }
]